APA

Loo D., Pryer N., Young P., Liang T., Coberly S., King K. L., Kang K., Roberts P., Tsao M., Xu X., Potts B. & Mather J. P. (20070620). The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo. : Molecular cancer therapeutics.

Chicago

Loo Deryk, Pryer Nancy, Young Peter, Liang Tony, Coberly Suzanne, King Kathleen L, Kang Key, Roberts Penny, Tsao Mary, Xu Xiaolin, Potts Beverly and Mather Jennie P. 20070620. The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo. : Molecular cancer therapeutics.

Harvard

Loo D., Pryer N., Young P., Liang T., Coberly S., King K. L., Kang K., Roberts P., Tsao M., Xu X., Potts B. and Mather J. P. (20070620). The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo. : Molecular cancer therapeutics.

MLA

Loo Deryk, Pryer Nancy, Young Peter, Liang Tony, Coberly Suzanne, King Kathleen L, Kang Key, Roberts Penny, Tsao Mary, Xu Xiaolin, Potts Beverly and Mather Jennie P. The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo. : Molecular cancer therapeutics. 20070620.